AARD vs SNDL · $284.4M cap vs $357.7M cap
Aardvark Therapeutics, Inc. Common Stock (AARD) versus SNDL Inc. (SNDL) — a side-by-side from cached financials, not a winner call.
Aardvark Therapeutics, Inc. Common Stock (AARD) is a biotechnology company listed on US.
SNDL Inc. (SNDL) is a beverages - wineries & distilleries company listed on US.
Latest reported AARD revenue for 2025-12-31 was $0. Net income was -$57.6M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. AARD currently screens at market cap $284.4M.
SNDL does not have a complete income-statement cache yet.
AARD currently screens at market cap $284.4M. SNDL currently screens at market cap $357.7M.
Not investment advice. Open the AARD and SNDL stock pages for the full models.
Not investment advice.